Nitric Oxide Regulation of Free Radical- and Enzyme-Mediated Lipid and Lipoprotein Oxidation

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 20; no. 7; pp. 1707 - 1715
• Main Authors: Bloodsworth, Allison, O’Donnell, Valerie B, Freeman, Bruce A
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Heart Association, Inc 01-07-2000; Hagerstown, MD Lippincott
• Subjects: Animals; Arteriosclerosis - metabolism; Biological and medical sciences; Blood vessels and receptors; Endothelium, Vascular - enzymology; Free Radicals - metabolism; Fundamental and applied biological sciences. Psychology; Humans; Lipid Metabolism; Lipoproteins - metabolism; Nitrates - metabolism; Nitric Oxide - metabolism; Nitric Oxide Synthase - metabolism; Oxidation-Reduction; Vertebrates: cardiovascular system; Human; Enzyme; Lipids; Inflammation; Lipoprotein; Biological activity; Free radical; Signal transduction; Regulation(control); Nitric oxide; Blood vessel; Oxidation; Circulatory system; Vascular wall; Peroxidation
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/01.atv.20.7.1707

The regulation of nonenzymatic and enzymatic lipid oxidation reactions by nitric oxide (·NO) is potent and pervasive and reveals novel non–cGMP-dependent reactivities for this free radical inflammatory and signal transduction mediator. ·NO and its metabolites stimulate and inhibit lipid peroxidation reactions, modulate enzymatically catalyzed lipid oxidation, complex with lipid-reactive metals, and alter proinflammatory gene expression. Through these mechanisms, ·NO can regulate nonenzymatic lipid oxidation and the production of inflammatory and vasoactive eicosanoids by prostaglandin endoperoxide synthase and lipoxygenase. The accumulation of macrophages and oxidized low density lipoprotein within the vascular wall can also be modulated by ·NO. A key determinant of the pro-oxidant versus oxidant-protective influences of ·NO is the underlying oxidative status of tissue. When ·NO is in excess of surrounding oxidants, lipid oxidation and monocyte margination into the vascular wall are attenuated, producing antiatherogenic effects. However, when endogenous tissue rates of oxidant production are accelerated or when tissue oxidant defenses become depleted, ·NO gives rise to secondary oxidizing species that can increase membrane and lipoprotein lipid oxidation as well as foam cell formation in the vasculature, thus promoting proatherogenic effects. In summary, ·NO is a multifaceted molecule capable of reacting via multiple pathways to modulate lipid oxidation reactions, thereby impacting on tissue inflammatory reactions.